Compare CLPT & CCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLPT | CCD |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.6M | 579.8M |
| IPO Year | N/A | N/A |
| Metric | CLPT | CCD |
|---|---|---|
| Price | $14.69 | $22.62 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $27.67 | N/A |
| AVG Volume (30 Days) | ★ 635.3K | 96.1K |
| Earning Date | 02-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.61% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $34,332,000.00 | N/A |
| Revenue This Year | $18.93 | N/A |
| Revenue Next Year | $51.64 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.83 | N/A |
| 52 Week Low | $9.76 | $16.93 |
| 52 Week High | $30.10 | $24.68 |
| Indicator | CLPT | CCD |
|---|---|---|
| Relative Strength Index (RSI) | 49.28 | 68.63 |
| Support Level | $13.80 | $22.06 |
| Resistance Level | $16.58 | $21.95 |
| Average True Range (ATR) | 1.01 | 0.30 |
| MACD | 0.11 | 0.11 |
| Stochastic Oscillator | 37.34 | 93.58 |
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.